Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haralambos Raftopoulos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomed Research International|October 2, 2015
Chemotherapy-Induced Nausea and VomitingBernardo Leon Rapoport, Alexander Molasiotis, Haralambos Raftopoulos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Histologic assessment of non-small cell lung carcinoma after neoadjuvant therapyXiaolin Liu-Jarin, Mark B Stoopler, Haralambos Raftopoulos, et al.
Radiology|January 19, 2007
Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastasesAmol Mujoomdar, John H M Austin, Rohin Malhotra, et al.
Expert Opinion on Investigational Drugs|November 7, 2012
Activin receptor antagonists for cancer-related anemia and bone diseaseScott Z Fields, Shiroo Parshad, Madhurima Anne, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2007
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K Ramanathan, Joel Picus, Haralambos Raftopoulos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 16, 2015
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studiesHaralambos Raftopoulos, Abderrahmane Laadem, Paul J Hesketh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomed Research International|October 2, 2015
Chemotherapy-Induced Nausea and VomitingBernardo Leon Rapoport, Alexander Molasiotis, Haralambos Raftopoulos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Histologic assessment of non-small cell lung carcinoma after neoadjuvant therapyXiaolin Liu-Jarin, Mark B Stoopler, Haralambos Raftopoulos, et al.
Radiology|January 19, 2007
Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastasesAmol Mujoomdar, John H M Austin, Rohin Malhotra, et al.
Expert Opinion on Investigational Drugs|November 7, 2012
Activin receptor antagonists for cancer-related anemia and bone diseaseScott Z Fields, Shiroo Parshad, Madhurima Anne, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2007
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K Ramanathan, Joel Picus, Haralambos Raftopoulos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 16, 2015
Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studiesHaralambos Raftopoulos, Abderrahmane Laadem, Paul J Hesketh, et al.
Pageof 1